OncoSec Medical Inc


Maxim Weighs in on OncoSec Medical Inc (ONCS) Ahead of Immune Data Presentation

OncoSec Medical Inc (NASDAQ:ONCS) shares are rising almost 8% ahead of the biotech firm’s immune data presentation tomorrow at the American Association for …

Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Announces Fourth Quarter and Year End Results for Fiscal Year 2016

OncoSec Medical Inc (NASDAQ:ONCS) announced financial results for the fourth quarter and fiscal year ended July 31, 2016. “During the fourth quarter, we continued …

Company Update (NASDAQ:ONCS): OncoSec Medical Inc Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced Sharron Gargosky, PhD, has been appointed to Chief Clinical and Regulatory …

Company Update (NASDAQ:ONCS): OncoSec Medical Inc Presents Preliminary Findings from Head and Neck Phase II Clinical Trial at EUROGIN 2016 Conference

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today presented preliminary findings from OMS-I130, a Phase II clinical trial of ImmunoPulse™ …

Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Closes $10 Million At-The-Market Registered Direct Offering

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that it has closed its previously announced at-the-market registered direct offering …

Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Announces Second Quarter and YTD Results for Fiscal Year 2016 and Calendar 2016 Milestones

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced key corporate objectives as well as financial results for the second …

Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Opens New Headquarters and Research Facility in San Diego

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced the Company consolidated its three previous offices into one new …

Looking Ahead of Wall Street: GW Pharmaceuticals PLC- ADR (GWPH), Costco Wholesale Corporation (COST), OncoSec Medical Inc (ONCS), and AutoZone, Inc. (AZO)

Here’s what to watch for this week from GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Costco Wholesale Corporation (NASDAQ:COST), OncoSec Medical Inc (NASDAQ:ONCS), and AutoZone, Inc. (NYSE:AZO).

Company Update (NASDAQ:ONCS): OncoSec Medical Inc Closes $7.5 Million Registered Direct Offering

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that the Company has closed its previously announced registered direct offering …

Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Announces $7.5 Million Registered Direct Offering

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered into definitive agreements with institutional investors to …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts